萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Scott L Silliman, MD

Neurologist, Vascular Neurologist

4.9 /5 425 ratings

(904) 383-1022

Request appointment online

Provider profile Menu

Provider profile Menu

Research at a glance

Top areas of exploration

Stroke , 21 publications
Cerebral Hemorrhage , 16 publications
Genetic Predisposition to Disease , 12 publications
Brain Ischemia , 11 publications

Research activity

62 publications

3,916 citations

Why is this important?

Active clinical trials

ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke

Investigators: Benjamin T Alwood, Scott L Silliman
Status: Accepting Candidates
Ages: 18 Years - 90 Years
Sexes: All

ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke

Investigators: Benjamin T Alwood, Scott L Silliman
Status: Accepting Candidates
Ages: 18 Years - 90 Years
Sexes: All

My publications

62 publications

2011

APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study.

The Lancet. Neurology

鈥�

2011

Apoe Genotype Predicts Hematoma Volume and Expansion in Intracerebral Hemorrhage

2011

Genome Wide Association Study of Intracerebral Hemorrhage

2011

Local Hospital Networks for Clinical Trials in Stroke

2011

Variants At Apoe Influence Risk of Deep and Lobar Intracerebral Hemorrhage